SarahChen_PharmD said:claudia_zurich said: ...compounded vs brand cost and coverage...
Pushing back on SarahChen_PharmD here. The affordability discussion here usually stops at individual tactics. At list price this class is out of reach for most of the people who would benefit, and no amount of appeal strategy changes that — it is a pricing problem wearing a paperwork costume.